Myomo (MYO) Change in Accured Expenses (2016 - 2025)
Myomo (MYO) posted Change in Accured Expenses of -$1.4 million for Q3 2025, up 30.62% on a QoQ basis from -$2.0 million in Q2 2025, and down 251.21% year-over-year from $904822.0 in Q3 2024.
Myomo (MYO) Change in Accured Expenses (2016 - 2025) Analysis & Trends
Myomo's Change in Accured Expenses history runs 10 years deep, the most recent figure standing at -$1.4 million for Q3 2025.
- Quarterly Change in Accured Expenses fell 251.21% year-over-year to -$1.4 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $897995.0 (down 41.84% YoY) and the FY2024 annual result came in at $4.7 million, up 162.17% from the prior year.
- Change in Accured Expenses was -$1.4 million for Q3 2025 at Myomo, up from -$2.0 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $2.8 million in Q4 2024 and bottomed at -$2.0 million in Q2 2025.
- A 5-year average of $276958.9 and a median of $340854.0 in 2022 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2022 — Change in Accured Expenses jumped 6458.16% — and 2025, when it plunged 318.16%.
- Myomo's Change in Accured Expenses stood at $535997.0 in 2021, then sank by 183.53% to -$447716.0 in 2022, then climbed by 21.41% to -$351845.0 in 2023, then surged by 895.05% to $2.8 million in 2024, then plunged by 148.91% to -$1.4 million in 2025.
- Business Quant data shows MYO's Change in Accured Expenses at -$1.4 million in Q3 2025, -$2.0 million in Q2 2025, and $1.4 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 145.10 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -250.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 21.07 Mn |
| 10 | Myomo | 43.43 Mn | 24.46 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1.37 Mn |
| Sep 30, 2025 | -1.37 Mn |
| Jun 30, 2025 | -1.97 Mn |
| Jun 30, 2025 | -1.97 Mn |
| Mar 31, 2025 | 1.44 Mn |
| Mar 31, 2025 | 1.44 Mn |
| Dec 31, 2024 | 2.80 Mn |
| Dec 31, 2024 | 2.80 Mn |
| Sep 30, 2024 | 904,822.00 |
| Sep 30, 2024 | 904,822.00 |
| Jun 30, 2024 | 903,932.00 |
| Jun 30, 2024 | 903,932.00 |
| Mar 31, 2024 | 87,041.00 |
| Mar 31, 2024 | 87,041.00 |
| Dec 31, 2023 | -351,845.00 |
| Dec 31, 2023 | -351,845.00 |
| Sep 30, 2023 | 1.25 Mn |
| Sep 30, 2023 | 1.25 Mn |
| Jun 30, 2023 | 501,714.00 |
| Jun 30, 2023 | 501,714.00 |